Atlas Trials

Endocrine, Metabolic and Microbiome Influence on the Post-acute Sequelae SARS-CoV-2 (PASC)

Clinical trial NCT04860869 · COMPLETED

Trial details

NCT number
NCT04860869
Sponsor
The University of Texas Medical Branch, Galveston
Status
COMPLETED
Study type
OBSERVATIONAL
Covid19
Start date
2021-05-12
Primary completion
2022-05-31
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.